Search research articles
Contact Us
Filters
Showing results (281-290 of 299) with videos related to
Page
of 30
Sort By:
Journal of Lipid Research
|
September 27, 2014
PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE
Brandon Ason, José W A van der Hoorn, Joyce Chan, et al.
Nature Nanotechnology
|
June 9, 2025
High-fidelity single-spin shuttling in silicon
Maxim De Smet, Yuta Matsumoto, Anne-Marije J Zwerver, et al.
Journal of the American College of Cardiology
|
March 26, 2016
Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study
John R Teerlink, G Michael Felker, John J V McMurray, et al.
Lancet (London, England)
|
October 6, 2014
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Frederick J Raal, Evan A Stein, Robert Dufour, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 27, 2017
Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016
Alan R Katz, Alan Y Komeya, Robert D Kirkcaldy, et al.
Journal of the American College of Cardiology
|
October 20, 2018
Effect of Evolocumab on Coronary Plaque Composition
Stephen J Nicholls, Rishi Puri, Todd Anderson, et al.
Journal of the American College of Cardiology
|
October 23, 2012
Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins
Clapton S Dias, Adam J Shaywitz, Scott M Wasserman, et al.
JAMA
|
November 16, 2016
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial
Stephen J Nicholls, Rishi Puri, Todd Anderson, et al.
JAMA
|
April 4, 2016
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial
Steven E Nissen, Erik Stroes, Ricardo E Dent-Acosta, et al.
Emerging Infectious Diseases
|
April 19, 2017
Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA
John R Papp, A Jeanine Abrams, Evelyn Nash, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 299) with videos related to
Sort By:
Page
of 30
Journal of Lipid Research
|
September 27, 2014
PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE
Brandon Ason, José W A van der Hoorn, Joyce Chan, et al.
Nature Nanotechnology
|
June 9, 2025
High-fidelity single-spin shuttling in silicon
Maxim De Smet, Yuta Matsumoto, Anne-Marije J Zwerver, et al.
Journal of the American College of Cardiology
|
March 26, 2016
Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study
John R Teerlink, G Michael Felker, John J V McMurray, et al.
Lancet (London, England)
|
October 6, 2014
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Frederick J Raal, Evan A Stein, Robert Dufour, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 27, 2017
Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016
Alan R Katz, Alan Y Komeya, Robert D Kirkcaldy, et al.
Journal of the American College of Cardiology
|
October 20, 2018
Effect of Evolocumab on Coronary Plaque Composition
Stephen J Nicholls, Rishi Puri, Todd Anderson, et al.
Journal of the American College of Cardiology
|
October 23, 2012
Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins
Clapton S Dias, Adam J Shaywitz, Scott M Wasserman, et al.
JAMA
|
November 16, 2016
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial
Stephen J Nicholls, Rishi Puri, Todd Anderson, et al.
JAMA
|
April 4, 2016
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial
Steven E Nissen, Erik Stroes, Ricardo E Dent-Acosta, et al.
Emerging Infectious Diseases
|
April 19, 2017
Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA
John R Papp, A Jeanine Abrams, Evelyn Nash, et al.
Page
of 30